Kimberly Brandt
🏛️ Revolving DoorFormer Government Position:
Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on Finance
🤖
AI Overview
Kimberly Brandt has appeared in 2,426 federal lobbying filings at Tarplin, Downs & Young, LLC, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 10 policy areas.
2,426
Total Filings
1
Firms
50
Clients
10
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2021 | 619 | 53 |
| 2022 | 744 | 56 |
| 2023 | 601 | 57 |
| 2024 | 462 | 59 |
Firms
Tarplin, Downs & Young, LLC2426 filings
Top Clients
Abbott (Formerly Known as Alere INC.)84 filings
Biotechnology Industry Organization78 filings
Bd (Becton, Dickinson and Company)70 filings
Alzheimer's Association69 filings
Astrazeneca66 filings
Merck64 filings
Vertex Pharmaceuticals Incorporated63 filings
Novo Nordisk INC.61 filings
Blue Cross Blue Shield Association61 filings
The Amputee Coalition58 filings
Triple-s Management Corporation55 filings
Abbvie INC.55 filings
Amgen INC54 filings
Boehringer Ingelheim54 filings
Genentech, INC.51 filings
Gilead Sciences, INC.51 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.